RecruitingNCT07030348

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study


Sponsor

Do Hyun Park

Enrollment

263 participants

Start Date

Jan 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Purpose Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, and only 10 15% of all pancreatic cancer patients are operable or borderline operable. Therefore, there is an unmet need for early diagnosis of pancreatic cancer; however, biomarkers related to this are not well understood. This study aims to identify biomarkers for the early diagnosis of pancreatic cancer through duodenal pancreatic juice, which can be easily obtained through an endoscopy.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for early biomarkers (biological signals) of pancreatic cancer in fluid collected from the small intestine during routine upper endoscopy procedures, to improve early detection of this disease. **You may be eligible if:** - You are 19 or older - You are already scheduled for a gastroscopy (upper endoscopy), endoscopic ultrasound, or ERCP for a medical reason - You either have confirmed pancreatic cancer (any stage) OR are suspected to have it and are scheduled for a biopsy procedure - For the comparison group: you have a non-cancerous pancreas condition or no pancreatic disease **You may NOT be eligible if:** - You are not already scheduled for an endoscopic procedure - You are unable or unwilling to give informed consent - You have a condition that makes the fluid collection unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

University of Colorado Hospital

Aurora, Colorado, United States

Cleveland Clinic

Cleveland, Ohio, United States

Asan Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07030348


Related Trials